InvestorsHub Logo
Followers 80
Posts 24706
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 09/11/2017 8:49:06 AM

Monday, September 11, 2017 8:49:06 AM

Post# of 27624
CTRV - .507217 Pre-market now at .5915/.60

ContraVir Pharmaceuticals Receives HBV IND Approval for Tenofovir Exalidex (TXL™) in the United States



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.